Client Work Detail
matter
SGF Takes Part in TPG Capital's $1.3-Billion Privatization of Axcan Pharma
CLIENT
Société générale de financement ("SGF")
DATE
February 26, 2008
LAWYER(S)
Niko Veilleux, Renaud Coulombe, Martin Thériault, Derek Chiasson
On February 26, 2008, the Société générale de financement ("SGF") announced that it would invest $60 million directly into Axcan Pharma Inc. debt and equity in parallel with U.S.-based private equity group TPG Capital's all-cash acquisition of Axcan for $1.3 billion which was completed in November of 2007 after stockholder approval.
Headquartered in Mont-St-Hilaire, Québec and with offices in the United States and Europe, Axcan is a leading multinational specialty pharmaceutical company that develops and markets a broad line of prescription products to treat a range of gastrointestinal diseases and disorders. Their products are marketed in North America and Europe and through commercial collaborations in many markets around the world.
Click here to read the SGF's press release.
